Clinical Trials Sponsored by Xu Lei

Total 5906 results

Laboratorios Leti, S.L.

Completed

Immunotherapy With Depigmented and Polymerized Allergen Extract of Phleum Pratense

Asthma | Rhinitis, Allergic, Seasonal | Conjunctivitis, Allergic

Spain
Laboratorios Leti, S.L.

Completed

Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units

Rhinitis, Allergic, Seasonal | Conjunctivitis, Allergic

Spain
MEI Pharma, Inc.

Recruiting

A Study of Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL) | Acute Myeloid Leukemia (AML) | Mantle Cell Lymphoma (MCL) | Diffuse Large B-cell Lymphoma (DLBCL) | Follicular Lymphoma (FL) | Marginal Zone Lymphoma (MZL)

United States
MEI Pharma, Inc.

Active, not recruiting

ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer

Colorectal Cancer

United States
LEO Pharma
Bayer

Completed

Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis

Dermatitis, Atopic
LEO Pharma
Bayer

Completed

A Study of Azelaic Acid (AzA) 15% Gel in the Treatment of Seborrheic Dermatitis of the Face

Seborrheic Dermatitis on the Face

Germany
LEO Pharma
Bayer

Completed

Safety and Efficacy of Azelaic Acid Foam, 15 % in Papulopustular Rosacea

Papulopustular Rosacea

United States
LEO Pharma
Bayer

Completed

A Study of Azelaic Acid (AzA) 15% in Topical Treatment of Mild to Moderate Perioral Dermatitis

Perioral Dermatitis

Germany
LEO Pharma
Bayer

Completed

A Multicenter Trial of a Topical Medication for Papulopustular Rosacea Applied Twice Daily Versus Once Daily

Papulopustular Rosacea

Germany
Leti Pharma GmbH

Completed

Validation of Combined Symptom Medication Score (cSMS) in Allergic Patients

Allergic Asthma | Allergic Rhinoconjunctivitis

Germany
LEO Pharma
Bayer

Completed

Preferences & Treatment Satisfaction Drivers in Rosacea Patients

Rosacea

United States
LEO Pharma
Bayer

Completed

Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation

Healthy

United States
LEO Pharma
Bayer

Completed

A Study of Patient Concerns and Treatment Satisfaction in Patients Being Treated With Finacea Foam for Rosacea

Rosacea

United States
LEO Pharma
Bayer

Completed

Efficacy of Topical Azelaic Acid 15% Gel Plus Anti-inflammatory Dose Doxycycline or Metronidazole Gel 1% Plus Anti-inflammatory Dose Doxycycline in Moderate Papulopustular Rosacea

Papulopustular Rosacea

United States
Laboratorios Leti, S.L.

Terminated

Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen Extract

Allergic Asthma

Spain
Leti Pharma GmbH

Completed

Depigoid Birch 5000 Longterm Study in Adults and Adolescents

Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent Asthma | Sensitization Against Betula Alba (Birch) Pollen

Germany
Laboratorios Leti, S.L.

Completed

Biological Standardization of Platanus Acerifolia Allergen Extract

Allergy to Platanus Acerifolia

Spain
Laboratorios Leti, S.L.

Completed

Biological Standardization of Dermatophagoides Pteronyssinus Allergen Extract

Allergic Rhinitis | Allergic Asthma | Allergy Dermatophagoides Pteronyssinus

Spain
MEI Pharma, Inc.

Completed

OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer (OVATURE)

Peritoneal Neoplasms | Ovarian Cancer | Fallopian Tube Cancer

United States, Spain, Belgium, United Kingdom, Australia, Italy, Poland
MEI Pharma, Inc.

Completed

Phenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

United States, Australia
Laboratorios Leti, S.L.

Completed

Biological Standarization of Cupressus Arizonica Allergen Extract to Determine the Biological Activity in Histamine Equivalent Units (HEP)

Allergy to Tree Pollen

Spain
Laboratorios Leti, S.L.

Completed

Biological Potency of the Cat Epithelial Allergenic Extracts

Cat Allergy (Disorder)

Spain
Laboratorios Leti, S.L.

Completed

Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml).

Allergy | Rhinitis | Rhinoconjunctivitis | Seasonal Asthma

Spain
Laboratorios Leti, S.L.

Completed

Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass Pollen

Seasonal Allergic Rhinitis

Spain, Hungary
Leti Pharma GmbH

Completed

Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma

Allergic Rhinitis/Rhinoconjunctivitis +- Intermittent Asthma | Sensitization Against Phleum Pratense Pollen | Dose-Finding Study

Germany
Laboratorios Leti, S.L.

Completed

Biological Standardization of Blomia Tropicalis Allergen Extract

Allergy to Mites

Spain
Laboratorios Leti, S.L.

Completed

Biological Standardization of Dactylis Glomerata Allergen Extract

Allergy to Grass Pollen (Dactylis Glomerata)

Spain
Laboratorios Leti, S.L.

Completed

Efficacy-safety Study of Sublingual Immunotherapy With Depigmented-polymerized Pollen Extracts to Treat Rhinoconjunctivitis (GPIT)

Allergic Rhinoconjunctivitis

South Africa
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Eli Lilly and Company

Completed

Pharmacogenomic & Phase II Study of Gemcitabine and Pemetrexed in Non-Small-Cell Lung Cancer.

Lung Cancer

United States
Xu Liu
The Third Xiangya Hospital of Central South University; Yangpu District Central...

Not yet recruiting

Adjunctive Right Atrial Ablation for Persistent Atrial Fibrillation

Atrial Fibrillation, Persistent
Xiuning Le
M.D. Anderson Cancer Center; Eli Lilly and Company

Active, not recruiting

Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer | Metastatic Cancer | Advanced Cancer | EGFR Gene Mutation

United States
Eli Lilly and Company

Not yet recruiting

A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2)

Obesity | Weight Gain

United States, Taiwan, Australia, France, Germany, Canada, United Kingdom, Spain, Israel, Argentina, Mexico, Puerto Rico
Eli Lilly and Company

Not yet recruiting

A Study Comparing Abemaciclib Plus Temozolomide to Temozolomide Monotherapy in Children and Young Adults With High-grade Glioma Following Radiotherapy

Glioma

United States
Eli Lilly and Company

Recruiting

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Renal Function in Adults Living With Obesity (TRIUMPH-OUTCOMES)

Overweight and Obesity

United States, Australia, Italy, Hungary, Spain, Canada, Germany, Argentina, Belgium, Czechia, Greece, Israel, Austria, Brazil, Mexico, Netherlands, Romania, India, United Kingdom, Slovakia, Poland, Turkey, Puerto Rico, France, Denmark
Eli Lilly and Company

Recruiting

A Drug-Drug Interaction (DDI) Study of Orforglipron With Carbamazepine in Healthy Participants

Healthy

United States
Eli Lilly and Company

Recruiting

A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Belgium, Italy, United States, Bulgaria
Eli Lilly and Company

Not yet recruiting

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

Alzheimer Disease

United States, United Kingdom, Japan
Eli Lilly and Company

Recruiting

A Study of LY3841136 in Japanese Participants With Obesity or Overweight

Obesity | Overweight

Japan
Eli Lilly and Company

Recruiting

A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)

Healthy | Type 1 Diabetes Mellitus

Germany
Eli Lilly and Company

Recruiting

A Study of LY3537982 in Chinese Participants With Advanced Solid Tumors

Advanced Solid Tumors

China
Eli Lilly and Company

Recruiting

A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis

Plaque Psoriasis

United States
Eli Lilly and Company

Recruiting

A First-In-Human Study of LY3839840 in Healthy Participants

Healthy

United States
Eli Lilly and Company

Recruiting

A Chronic Weight Management Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Obesity | Overweight

United States
Eli Lilly and Company

Recruiting

A Study of LY3556050 in Adult Participants With Diabetic Peripheral Neuropathic Pain

Diabetic Peripheral Neuropathy

United States, Korea, Republic of, Japan, Czechia, Poland
Eli Lilly and Company

Recruiting

A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Obesity | Overweight

United States, Canada, Italy, Czechia, Israel, Mexico, Poland
Eli Lilly and Company

Recruiting

A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin (ACHIEVE-3)

Type 2 Diabetes

United States, China, Japan, Argentina, Puerto Rico, Mexico
Eli Lilly and Company

Recruiting

A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Hidradenitis Suppurativa

United States, Australia, Canada, Germany, Greece, Poland
Eli Lilly and Company

Recruiting

A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)

Dyslipidemias | Non-Alcoholic Fatty Liver Disease

United States
Eli Lilly and Company

Recruiting

A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (ACHIEVE-1)

Type 2 Diabetes

United States, Mexico, Japan, India, Puerto Rico, China
Eli Lilly and Company

Recruiting

A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes

Type 2 Diabetes | CKD | Overweight or Obesity

Italy, United States, United Kingdom, Canada, Spain

Clinical Trials Sponsored by Xu Lei

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations